Sort
46,585 grants matching “heart failure”
Metabolic profiling and comprehensive metabolic pathway mapping: a systems biology approach to cardiovascular failure and organ injury following infant congenital heart disease surgery
$623,434Jesse Davidson · University Of Colorado Denver · R01 · FY2022 · HL
Improving Hypertension Medication Adherence for Older Adults
$623,423Jeannie Kim Lee · University Of Arizona · R01 · FY2020 · NR
Repair and Angiogenesis by Stem Cells in Human Heart
$623,349Piero Anversa · Brigham And Women'S Hospital · R37 · FY2008 · HL
Mapping the cell specific DNA damage-induced molecular and bioelectrical responses in the 3D cardiac unit
$623,154Tzahi Cohen-Karni · Carnegie-Mellon University · R01 · FY2023 · HL
ASCEND (ARDS in Children and ECMO initiation strategies impact on Neuro-Development)
$623,000Ryan Pasquale Barbaro · University Of Michigan At Ann Arbor · R01 · FY2022 · HL
Functional assay development for tafazzin enzyme replacement candidate selection
$623,000Michael T Chin · Tufts Medical Center · R61 · FY2021 · HL
Functional assay development for tafazzin enzyme replacement candidate selection
$623,000Michael T Chin · Tufts Medical Center · R33 · FY2023 · HL
Role of Cardiac Myosin Binding Protein-C in the Regulation of Myocardial Contraction
$622,935Samantha P Harris · University Of Arizona · R01 · FY2024 · HL
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
$622,925Yang K Xiang · University Of California At Davis · R01 · FY2024 · HL
Aldosterone Synthase & Hypertension
$622,916Ashok Kumar Kumar · University Of Toledo Health Sci Campus · R01 · FY2015 · HL
Leveraging Health Information Technology to Improve Trauma Resuscitation
$622,894Michael H. Metzler · Lifeboard Medical · R44 · FY2023 · LM
High-throughput Human Micro-Heart Muscle for Drug Discovery
$622,880Samuel Wall · Organos, Inc. · R44 · FY2022 · TR
Treatment of Muscular Dystrophy-associated Dilated Cardiomyopathy with P-188
$622,877Bruce E. Markham · Phrixus Pharmaceuticals, Inc. · R43 · FY2012 · HL
Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology
$622,841Alexander Egbe · Mayo Clinic Rochester · R01 · FY2024 · HL
Regulation of Cardiac Collagen Content by SLIT3
$622,822Ming-Sing Si · University Of California Los Angeles · R01 · FY2025 · HL
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
$622,786Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2011 · HL
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
$622,706Jordana B. Cohen · University Of Pennsylvania · R01 · FY2024 · HL
VIDA: Virtual Diabetes Group Visits Across Health Systems
$622,687Arshiya Ahmed Baig · University Of Chicago · P50 · FY2022 · MD
A functional genomics pipeline for genetic discovery in diabetic kidney disease
$622,668Joel N Hirschhorn · Broad Institute, Inc. · R01 · FY2025 · DK
Longitudinal Study of Predictors and Consequences of Chronic Kidney Disease
$622,648Josef Coresh · Johns Hopkins University · R01 · FY2011 · DK
Associations of smoke from wildfires and prescribed burns with cardiorespiratory health outcomes in Reno, NV
$622,643Matthew J. Strickland · University Of Nevada Reno · R01 · FY2019 · ES
Post-Acute Care Medication Use and Functional Recovery in Heart Failure
$622,634Andrew Reis Zullo · Brown University · R01 · FY2025 · AG
Characterization of beta-arrestin-biased beta 2-adrenergic receptor signaling in cardiovascular function
$622,632Jeffrey L Benovic · Thomas Jefferson University · R01 · FY2018 · HL
The Cardiac Atlas Project
$622,573Andrew D. McCulloch · University Of California, San Diego · R01 · FY2020 · HL
Pig Core
$622,559Steven R Houser · Temple Univ Of The Commonwealth · P01 · FY2014 · HL